Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer: Risk Stratified MonoTherapy Versus RADIOSURGERY Boost

NCT04552509 is registered in ClinicalTrials.gov with Linda Chan, MD as lead sponsor.

NCT NCT04552509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04552509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer: Risk Stratified MonoTherapy Versus RADIOSURGERY Boost
Lead sponsor
Linda Chan, MD
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 5, 2018
Completion date
December 1, 2026
Enrollment
167 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer